KORU Medical Systems Inc. (KRMD): רווח למניה בשנים עשר החודשים האחרונים

KORU Medical Systems automates home infusion, although regulatory delays and competition create certain risks. The trailing twelve-month net income per share on the GURU.Markets terminal chart confirms the impact of these factors, where -0.02 represents the current metric. The impeccable image of the Freedom brand and physician trust provide the company with high stability.

Annual net income per share measures the real equity return of a business by dividing total net income by the number of securities to evaluate fundamental efficiency. By analyzing the annual net income per share trend, an investor determines capital stability, which at KORU Medical Systems (KRMD) is supported by the automation of infusion system production and strict polymer quality control in New York.